FrancophonIA/ELRC3.0 huggingface dataset:
English: (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), or very rare (<1/10,000), and not known (cannot be estimated from the available data).
Slovenian: Pogostnosti so opredeljene kot zelo pogosti (≥1/10), pogosti (≥1/100 do <1/10), občasni (≥ 1/1.000 do <1/100), redki (≥1/10.000 do <1/1.000) in zelo redki (<1/10.000) ali neznana pogostnost (ni mogoče oceniti iz razpoložljivih podatkov).
English: Synjardy should be discontinued, at least temporarily, until the situation is clarified.
Slovenian: Jemanje zdravila Synjardy je treba vsaj začasno prekiniti, dokler se stanje ne razjasni.
English: Ketoacidosis is a condition in which substances called ‘ketone bodies' accumulate in the blood and which can lead to diabetic precoma.
Slovenian: Ketoacidoza je stanje, v katerem se snovi, imenovane ‘ketonska telesa', nakopičijo v krvi, in lahko privede do diabetične predkome.
English: As this medicinal product contains metformin, the treatment must be discontinued 48 hours before elective surgery with general, spinal or peridural anaesthesia.
Slovenian: Ker to zdravilo vsebuje metformin, je treba zdravljenje z njim prekiniti 48 ur pred elektivnim kirurškim posegom v splošni, spinalni ali epiduralni anesteziji.
English: Patients should be instructed to notify these signs immediately to their physicians if they occur, notably if patients had a good tolerance to Synjardy before.
Slovenian: Bolnikom naročite, da ob pojavu navedenih znakov nemudoma obvestijo svojega zdravnika, zlasti, če so bolniki pred tem dobro prenašali zdravilo Synjardy.
English: By blocking this protein, the medicine causes blood sugar to be removed via the urine.
Slovenian: Z zaviranjem te beljakovine zdravilo povzroča izločanje krvnega sladkorja z urinom.
English: Stop taking Synjardy and see a doctor as soon as possible if you notice any of the following serious or potentially serious side effects:
Slovenian: Takoj prenehajte jemati zdravilo Synjardy in se posvetujte z zdravnikom, če opazite katerega od naslednjih resnih ali potencialno resnih neželenih učinkov:
English: Physicians should alert the patients on the risk and on the symptoms of lactic acidosis.
Slovenian: Zdravniki morajo bolnike opozoriti o tveganju in simptomih laktacidoze.
English: Reintroduction of Synjardy should then be discussed taking into account the benefit/risk ratio in an individual basis as well as renal function.
Slovenian: O ponovni uvedbi zdravila Synjardy se je treba pogovoriti ob upoštevanju razmerja med koristjo in tveganjem pri posamezniku ter delovanja ledvic.
English: If necessary, the dose of the anti-hyperglycaemic medicinal product should be adjusted during therapy with the other medicinal product and on its discontinuation.
Slovenian: Po potrebi je treba med zdravljenjem z drugim zdravilom ali ob njegovi ukinitvi prilagoditi odmerek antihiperglikemičnega zdravila.
English: In these cases, it is also recommended to check renal function before initiating treatment with Synjardy.
Slovenian: V tovrstnih primerih je priporočljivo tudi preveriti delovanje ledvic pred pričetkom zdravljenja z zdravilom Synjardy.
English: Your doctor may ask you to stop taking Synjardy until you recover to prevent loss of too much body fluid;
Slovenian: Vaš zdravnik vam bo morda naročil, da zdravilo Synjardy prenehate jemati, dokler ne okrevate, da preprečite izgubo prevelike količine telesnih tekočin;
English: Please note the following particular risk of lactic acidosis.
Slovenian: Bodite pozorni predvsem na naslednja tveganja za laktacidozo.
English: Possible signs of losing too much fluid from your body are listed in section 4 ‘Possible side effects'.
Slovenian: Možni znaki pretirane izgube tekočine iz telesa so našteti v poglavju 4, “Možni neželeni učinki”;
English: This medicinal product must not be used in patients with moderate or severe renal impairment (creatinine clearance <60 ml/min) (see sections 4.3 and 4.4).
Slovenian: To zdravilo se ne sme uporabljati pri bolnikih z zmerno ali hudo ledvično okvaro (kreatininski očistek < 60 ml/min) (glejte poglavji 4.3 in 4.4).
English: Patients (%) achieving
Slovenian: Bolniki (%) z izhodiščno vrednostjo
English: Body Weight (kg) at week 52b
Slovenian: Telesna masa (kg) v 52. tednu b
English: In the acute conditions listed, metformin should be temporarily discontinued.
Slovenian: Ob navedenih akutnih stanjih je treba začasno prekiniti zdravljenje z metforminom.
English: You will need to tell your doctor and stop taking this medicine before, or at the time of the X-ray and for 2 or more days after depending on how your kidneys are working.
Slovenian: O tem boste morali obvestiti zdravnika in prenehati jemati to zdravilo pred ali na dan rentgenskega slikanja ter še 2 ali več dni po preiskavi, odvisno od delovanja ledvic.
English: It is important to you to comply with your medication intake, dietary instructions and regular exercise program because this can reduce the risk of lactic acidosis.
Slovenian: Pomembno je, da pravilno jemljete zdravilo in upoštevate navodila glede prehrane ter program redne telesne vadbe, saj lahko s tem zmanjšate tveganje za nastanek laktacidoze.
English: N SBP (mmHg)3
Slovenian: N Vrednost SBP (mmHg)2
English: • a medicine used to remove water from the body (diuretic), as Synjardy may increase the risk of losing too much fluid.
Slovenian: • zdravilo, ki iz telesa odvaja tekočino (diuretik), saj lahko zdravilo Synjardy poveča tveganje za pretirano izgubo tekočine.
English: The patient should be informed and more frequent blood glucose monitoring performed, especially at the beginning of treatment with such medicinal products.
Slovenian: Bolnika je treba s tem seznaniti in zlasti na začetku zdravljenja s temi zdravili pogosteje spremljati njegovo raven glukoze v krvi.
English: Lactic acidosis is a very rare, but serious (high mortality in the absence of prompt treatment), metabolic complication that can occur due to metformin accumulation.
Slovenian: Laktacidoza je zelo redek, ampak resen presnovni zaplet (zaradi visoke umrljivosti, če ni takojšnjega zdravljenja), ki ga lahko povzroči kopičenje metformina.
English: It particularly affects patients whose kidneys are not working properly.
Slovenian: Zlasti prizadene bolnike, ki imajo težave z delovanjem ledvic.
English: In case of lactic acidosis, the patient should be hospitalised immediately (see section 4.9).
Slovenian: Ob pojavu laktacidoze je treba bolnika nemudoma sprejeti v bolnišnico (glejte poglavje 4.9).
English: Synjardy can also be combined with other medicines.
Slovenian: Zdravilo Synjardy se lahko uporablja tudi v kombinaciji z drugimi zdravili.
English: Decreased renal function in elderly patients is frequent and asymptomatic.
Slovenian: Zmanjšano delovanje ledvic je pri starejših ljudeh pogosto in asimptomatično.
English: a derived from postmarketing experience b see section 4.4
Slovenian: a Izhaja iz izkušenj v obdobju trženja b
English: Therapy should usually not be resumed earlier than 48 hours following surgery and only after renal function has been reevaluated and found to be normal.
Slovenian: Zdravljenje z zdravilom se navadno ne sme ponovno uvesti prej kot 48 ur po kirurškem posegu in šele po ponovni oceni delovanja ledvic, če je izvid normalen.
English: Empagliflozin is a reversible, highly potent (IC50 of 1.3 nmol) and selective competitive inhibitor of SGLT2.
Slovenian: Empagliflozin je reverzibilen, izjemno močan (IC50 1,3 nmol) in selektiven kompetitiven zaviralec
English: You should stop taking Synjardy at least 48 hours before planned surgery with general, spinal or peridural anaesthesia and should not start again until at least 48 hours afterwards.
Slovenian: Zdravilo Synjardy boste morali prenehati jemati vsaj 48 ur pred načrtovano operacijo v splošni, spinalni ali epiduralni anesteziji, zdravljenje pa smete znova nadaljevati najmanj 48 ur po posegu.
English: • if you need to have an injection of contrast agent that contains iodine, for example before an X-ray or scan.
Slovenian: • če morate prejeti injekcijo jodiranega kontrastnega sredstva, npr. pred rentgenskim ali drugačnim slikanjem.
English: Synjardy should not be used in patients with type 1 diabetes.
Slovenian: Zdravila Synjardy ne smejo uporabljati bolniki s sladkorno boleznijo tipa 1.
English: Diagnostic laboratory findings are decreased blood pH, plasma lactate levels above 5 mmol/l, and an increased anion gap and lactate/pyruvate ratio.
Slovenian: Diagnostični laboratorijski izvidi kažejo znižano pH-vrednost krvi, raven laktatov v plazmi nad 5 mmol/l ter povečano anionsko vrzel in razmerje laktati/piruvat.
English: Metformin The prospective randomised (UKPDS) study has established the long-term benefit of intensive blood glucose control in type 2 diabetes.
Slovenian: V prospektivni randomizirani študiji (UKDPS) je bila dokazana dolgoročna korist intenzivnega urejanja glukoze v krvi pri sladkorni bolezni tipa 2.
English: Difference from placebo1
Slovenian: Razlika glede na placebo1
English: Other medicines and Synjardy Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Slovenian: Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: Metformin, one of the active substances in this medicine, can cause a very rare (may affect up to 1 in 10,000 people) but serious side effect called ‘lactic acidosis'.
Slovenian: Metformin, ena od zdravilnih učinkovin tega zdravila, lahko povzroči zelo redek (pojavi se lahko pri največ 1 od 10.000 bolnikov), a resen neželeni učinek “laktacidozo”.
English: Treatment with empagliflozin once daily resulted in statistically significant improvement in HbA1c, and 24 hour mean systolic and diastolic blood pressure as determined by ambulatory blood pressure monitoring (Table 6).
Slovenian: Zdravljenje z empagliflozinom enkrat na dan je povzročilo statistično značilno izboljšanje HbA1c in 24-urnega povprečnega sistoličnega in diastoličnega krvnega tlaka, kot je bilo ugotovljeno z ambulantnim spremljanjem krvnega tlaka (preglednica 6).
English: • Diabetic ketoacidosis, diabetic pre-coma.
Slovenian: • Diabetična ketoacidoza, diabetična predkoma.
English: ketoacidosisa, b Lactic acidosis3
Slovenian: ketoacidozaa, b laktacidoza pomanjkanje vitamina
English: Of these, a total of 530 patients received empagliflozin as add-on to metformin plus insulin, of which 266 patients were treated with empagliflozin 10 mg and 264 with empagliflozin 25 mg.
Slovenian: Od teh je skupno 530 bolnikov prejemalo empagliflozin kot dodatno zdravljenje k metforminu in insulinu, od teh pa je bilo 266 bolnikov zdravljenih z empagliflozinom 10 mg in 264 z empagliflozinom 25 mg.
English: 5 Gastrointestinal symptoms such as nausea, vomiting, diarrhoea, abdominal pain and loss of appetite occur most frequently during initiation of therapy and resolve spontaneously in most cases.
Slovenian: 5 Prebavni simptomi, kot so slabost, bruhanje, driska, trebušne bolečine in zmanjšan tek, se najpogosteje pojavljajo na začetku zdravljenja ter večinoma spontano minejo.
English: Following administration of an oral [14C]-empagliflozin solution to healthy volunteers, approximately 96% of the drug-related radioactivity was eliminated in faeces (41%) or urine (54%).
Slovenian: [14C]-empagliflozina se je pri zdravih prostovoljcih približno 96 % radioaktivnosti, povezane z zdravilom, izločilo v blato (41 %) ali urin (54 %).
English: The majority of drug-related radioactivity recovered in faeces was unchanged parent drug and approximately half of drug-related radioactivity excreted in urine was unchanged parent drug.
Slovenian: Večina radioaktivnosti v blatu, povezane z zdravilom je bila nespremenjena izhodna učinkovina in približno polovica radioaktivnosti v urinu,
English: The frequency of patients with hypoglycaemic events was similar for empagliflozin and placebo as add-on to metformin.
Slovenian: Pogostnost bolnikov s hipoglikemičnimi dogodki je bila podobna za empagliflozin in placebo kot dodatno zdravljenje k metforminu.
English: Lactic acidosis is characterised by acidotic dyspnea, abdominal pain and hypothermia followed by coma.
Slovenian: Za laktacidozo so značilni acidozna dispneja, trebušne bolečine in hipotermija, ki ji sledi koma.
English: Hypoglycaemia (when used with sulphonylurea or insulin)1
Slovenian: Presnovne in prehranske motnje hipoglikemija (pri uporabi s sulfonilsečnino ali insulinom)1
English: Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection1, 2
Slovenian: Infekcijske in parazitske bolezni vaginalna kandidoza, vulvovaginitis, balanitis in druge okužbe spolovil1,
English: Reported cases of lactic acidosis in patients on metformin have occurred primarily in diabetic patients with renal failure or acute worsening of renal function.
Slovenian: Primeri laktacidoze, o katerih so poročali pri bolnikih, ki jemljejo metformin, so se pojavili zlasti pri sladkornih bolnikih z okvaro ledvic ali akutnim poslabšanjem delovanja ledvic.
English: These may be medicines taken by mouth or insulin given by injection.
Slovenian: To so lahko zdravila, ki se jemljejo peroralno (se zaužijejo) ali pa je to insulin, ki se injicira.
English: Difference from glimepiride1 (97.5% CI)
Slovenian: Razlika glede na glimepirid1 (97,5-odstotni
English: Gastrointestinal symptoms3, 5
Slovenian: Bolezni prebavil prebavni simptomi3, 5
English: • if you have uncontrolled diabetes, with e.g. severe hyperglycaemia (high blood glucose), nausea, vomiting, dehydration, rapid weight loss or ketoacidosis.
Slovenian: • če imate nekontrolirano sladkorno bolezen s hudo hiperglikemijo (povišan krvni sladkor), slabostjo, bruhanjem, dehidracijo, hitro izgubo telesne mase ali ketoacidozo.
English: Do not stop taking Synjardy without first consulting your doctor.
Slovenian: Če ste prenehali jemati zdravilo Synjardy Ne prenehajte jemati zdravila Synjardy, ne da bi se prej posvetovali z zdravnikom.
English: Your doctor may ask you to stop taking Synjardy until you have recovered;
Slovenian: Vaš zdravnik vam bo morda naročil, da zdravilo Synjardy prenehate jemati, dokler ne okrevate;
English: There is an increased risk of lactic acidosis following excessive alcohol consumption (particularly in the case of fasting, malnutrition, or liver disease).
Slovenian: Nevarnost laktacidoze je povečana pri prekomernem uživanju alkohola (zlasti ob postu, podhranjenosti ali jetrni okvari).
English: Liver function tests abnormalities3 Hepatitis3
Slovenian: žolčnika in žolčevodov nenormalni izvidi testov jetrnih funkcij3 hepatitis3
English: • if you drink alcohol to excess, either every day or only from time to time (see section “Synjardy with alcohol”).
Slovenian: • če imate težave z jetri; • če vsak dan ali samo občasno pijete prevelike količine alkohola (glejte poglavje “Zdravilo
English: Stop taking this medicine immediately and contact a doctor or the nearest hospital straight away (see section 4).
Slovenian: Takoj prenehajte jemati to zdravilo in se obrnite na zdravnika ali takoj pojdite v bolnišnico (glejte poglavje 4).
English: Due to its mechanism of action, patients taking Synjardy will test positive for glucose in their urine.
Slovenian: Zaradi mehanizma delovanja bodo rezultati testov glukoze v urinu pri bolnikih, ki jemljejo zdravilo Synjardy, pozitivni.
English: There is increased risk of lactic acidosis in acute alcohol intoxication (particularly in the case of fasting, malnutrition or hepatic impairment due to the metformin active substance (see section 4.4)).
Slovenian: Nevarnost laktacidoze je povečana pri akutni zastrupitvi z alkoholom (zlasti ob postu, podhranjenosti ali jetrni okvari, zaradi zdravilne učinkovine metformina (glejte poglavje 4.4)).
English: 1 See subsections below for additional information
Slovenian: 1 Za dodatne informacije glejte spodnja podpoglavja.
English: Complicated urinary tract infection (e.g. pyelonephritis or urosepsis) occurred at a similar frequency in patients treated with empagliflozin compared to placebo.
Slovenian: Zapletene okužbe sečil (npr. pielonefritis ali urosepsa) so se pri bolnikih, zdravljenih z empagliflozinom, pojavile s podobno pogostnostjo kot pri placebu.
English: Biotransformation Metformin is excreted unchanged in the urine.
Slovenian: Metformin se nespremenjen izloči z urinom.
English: Table 1 Adverse reactions reported in placebo-controlled studies System organ class
Slovenian: Preglednica 1: Neželeni učinki, o katerih so poročali v s placebom nadzorovanih študijah
English: The European Medicines Agency has waived the obligation to submit the results of studies with Synjardy in all subsets of the paediatric population in type 2 diabetes (see section 4.2 for information on paediatric use).
Slovenian: Synjardy za vse podskupine pediatrične populacije s sladkorno boleznijo tipa 2 (za podatke o uporabi pri pediatrični populaciji glejte poglavje 4.2).
English: Dysuria2
Slovenian: disurija2
English: The risk of developing lactic acidosis is also increased with uncontrolled diabetes, prolonged fasting or alcohol intake, body fluid deficit (dehydration) due to severe diarrhoea or vomiting, liver problems and any medical conditions in which a region of the body is deprived with a lack of oxygen supply (such as acute severe heart diseases).
Slovenian: Tveganje za nastanek laktacidoze je povečano tudi ob nenadzorovani sladkorni bolezni, dolgotrajnejšem postu ali uživanju alkohola, pomanjkanju telesnih tekočin (dehidracija) zaradi hude driske ali bruhanja, težavah z jetri in vsakem stanju, pri katerem ima del telesa pomanjkljivo oskrbo s kisikom (kot so akutna in huda obolenja srca).
English: Experience in New York Heart Association (NYHA) class I-II is limited, and there is no experience in clinical studies with empagliflozin in NYHA class III-IV.
Slovenian: Heart Association) so omejene, izkušenj iz kliničnih študij z empagliflozinom z razredom III-IV po
English: At Week 18, empagliflozin provided statistically significant improvement in HbA1c compared with placebo (Table 4).
Slovenian: V 18. tednu je pri empagliflozinu prišlo do statistično značilnega izboljšanja vrednosti HbA1c v primerjavi s placebom (preglednica 4).
English: Symptoms include rapid weight loss, feeling sick or being sick, stomach pain, fast and deep breathing, sleepiness or unusual fruity odour of the breath;
Slovenian: Simptomi vključujejo hitro izgubo telesne mase, občutek slabosti ali bruhanje, trebušne bolečine, hitro in globoko dihanje, zaspanost ali nenavaden saden zadah.
English: Other associated risk factors should be considered to avoid lactic acidosis such as poorly controlled diabetes, ketosis, prolonged fasting, excessive alcohol intake, hepatic impairment and any condition associated with hypoxia (such as decompensated cardiac failure, acute myocardial infarction) (see section 4.3).
Slovenian: Da bi preprečili pojav laktacidoze, je treba upoštevati tudi druge povezane dejavnike tveganja, kot so slabo nadzorovana sladkorna bolezen, ketoza, dolgotrajnejši post, čezmerno uživanje alkohola, jetrna okvara in vsako stanje, ki je povezano s hipoksijo (kot je dekompenzirano srčno popuščanje, akutni miokardni infarkt) (glejte poglavje 4.3).
English: Stop taking Synjardy immediately and contact a doctor or the nearest hospital straight away.
Slovenian: Takoj prenehajte jemati zdravilo Synjardy in se nemudoma posvetujte z zdravnikom ali pojdite v najbližjo bolnišnico.
English: If this happens to you, you may need immediate hospital treatment, as lactic acidosis may lead to coma.
Slovenian: Če se pri vas pojavijo ti simptomi, boste morda potrebovali takojšnje bolnišnično zdravljenje, saj lahko laktacidoza vodi v komo.
English: If you experience some of these symptoms, you should seek immediately medical attention, as lactic acidosis may lead to coma.
Slovenian: Če opazite katerega izmed teh simptomov, nemudoma pokličite zdravnika, saj lahko laktacidoza vodi v komo.
English: Hypoglycaemia The frequency of hypoglycaemia depended on the background therapy in the respective studies.
Slovenian: Hipoglikemija Pogostnost hipoglikemije je bila odvisna od sočasno uporabljenih zdravil v zadevnih študijah.
English: The efficacy and safety of empagliflozin as add on to basal insulin with concomitant metformin therapy was evaluated in a double-blind, placebo-controlled trial of 78 weeks duration.
Slovenian: Učinkovitost in varnost empagliflozina kot dodatnega zdravljenja k bazalnemu insulinu s sočasnim metforminom so ocenili v dvojno slepem, s placebom nadzorovanem 78-tedenskem preskušanju.
English: Empagliflozin as add-on to metformin, sulphonylurea, pioglitazone Empagliflozin as add-on to metformin, metformin and a sulphonylurea, or pioglitazone and metformin resulted in statistically significant (p<0.0001) reductions in HbA1c and body weight compared to placebo (Table 2).
Slovenian: Empagliflozin kot dodatno zdravljenje k metforminu, sulfonilsečnini, pioglitazonu Empagliflozin kot dodatno zdravljenje k metforminu, metforminu s sulfonilsečnino ali pioglitazonu z metforminom je povzročilo statistično značilno (p < 0,0001) zmanjšanje vrednosti HbA1c in telesne mase v primerjavi s placebom (preglednica 2).
English: Therefore, avoid consumption of alcohol and medicines containing alcohol when taking Synjardy (see section 4, ‘Possible side effects').
Slovenian: Če jemljete zdravilo Synjardy, ne uživajte alkohola in ne uporabljajte zdravil, ki ga vsebujejo (glejte poglavje 4 “Možni neželeni učinki”).
English: (95% CI) a Full analysis set (FAS)
Slovenian: Razlika glede na placebo5 (95-odstotni IZ) a Niz celotne analize (FAS, full analysis set)
English: • difficulty breathing
Slovenian: • huda utrujenost • težave z dihanjem
English: The intravascular administration of iodinated contrast agents in radiological studies may lead to renal failure, resulting in metformin accumulation and a risk of lactic acidosis.
Slovenian: Intravaskularno dajanje jodiranih kontrastnih sredstev v radioloških študijah lahko pripelje do ledvične odpovedi, ki povzroči kopičenje metformina in s tem tveganje za pojav laktacidoze.
English: Placebo
Slovenian: za placebo.
English: Special caution should be paid to situations where renal function may become impaired, for example in case of dehydration (severe diarrhoea or vomiting), or when initiating antihypertensive therapy or diuretic therapy and when starting therapy with a non-steroidal anti-inflammatory drug (NSAID).
Slovenian: Posebna previdnost je potrebna v razmerah, v katerih bi se lahko delovanje ledvic poslabšalo, na primer ob dehidraciji (huda driska ali bruhanje) ali ob začetku zdravljenja z antihipertenzivom, diuretikom ali nesteroidnim protivnetnim zdravilom (NSAID).
English: For patients inadequately controlled on metformin monotherapy or metformin in combination with other glucose-lowering medicinal products including insulin In patients not adequately controlled on metformin alone or in combination with other glucose-lowering medicinal products, including insulin, the recommended starting dose of Synjardy should provide empagliflozin 5 mg twice daily (10 mg daily dose) and the dose of metformin similar to the dose already being taken.
Slovenian: Pri bolnikih z nezadostno urejeno boleznijo pri jemanju metformina v monoterapiji ali v kombinaciji z drugimi zdravili, ki nižajo raven glukoze, vključno z insulinom Priporočeni začetni odmerek zdravila Synjardy pri bolnikih z nezadostno urejeno boleznijo pri jemanju metformina v monoterapiji ali v kombinaciji z drugimi zdravili, ki nižajo raven glukoze, vključno z insulinom, je 5 mg empagliflozina dvakrat dnevno (dnevni odmerek je 10 mg) s podobnim odmerkom metformina, kot so ga že jemali.
English: The following statements reflect the pharmacokinetic properties of the individual active substances of Synjardy.
Slovenian: Spodnje trditve temeljijo na farmakokinetičnih lastnostih posameznih zdravilnih učinkovin zdravila
English: SGLT2 prevents glucose (blood sugar) from being lost in urine by absorbing glucose back into the bloodstream as blood is being filtered in the kidneys.
Slovenian: (krvnega sladkorja) v urinu, tako da absorbira glukozo nazaj v krvni obtok, medtem ko se kri filtrira v ledvicah.